Type 2 Diabetes leading Japanese clinical trials, 2012-2016
As part of our series of white papers tracking clinical trials activity across the world, GlobalData recently compiled a summary of the clinical trials initiated in Japan.
Focus:
As part of our series of white papers tracking clinical trials activity across the world, GlobalData recently compiled a summary of the clinical trials initiated in Japan.
The Japanese drug delivery devices market is expected to increase from $2.56bn in 2016, to $3.4bn by 2023, according to a report by GlobalData.
As medical technology continually advances and clinical practice evolves, some technologies inevitably become redundant.
Migraine is typically characterised by recurring headaches and throbbing pain on one side of the head, accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most people...
The global medical devices market was estimated to be worth more than $450bn with a compound annual growth rate (CAGR) of 3.9% in 2017. Competition is fierce, with each company...
Although one of the smallest orthopedic markets by revenue in 2016, small joint replacement is expected to experience the fastest growth of all orthopedic markets through 2023.
Billions of people worldwide suffer from chronic wounds, surgical wounds, burns, and trauma every year. The number of non-healing wound cases and expenditures are expected to rise as a natural...
The Asia-Pacific pedicle screw-based dynamic stabilisation systems market is forecast to witness a compound annual growth rate (CAGR) of 6.3% from $12.5m in 2016, to $19.2m by 2023, according to...
Prompt hemostasis and effective incision closure have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon’s toolbox expands to include more effective products such as biosurgery...
The revision knee replacement market in Europe is expected to grow modestly from $259m in 2016, to $304m by 2023, representing a compound annual growth rate (CAGR) of 2.3%, according...